SO-004 - A phase 1b study of IMU-131 her2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

Autor: Maglakelidze, M., Yau, T., Bulat, I., Yen, C., Chao, Y., Bai, L., Good, A., Ede, N., Chong, L., Tanasanvimon, S., Charoetum, C., Loong, H., Lausoontornsiri, W., Arpornwirat, W., Maneechavakajon, J., Ungtrakul, T., Chou, W.
Zdroj: In Annals of Oncology July 2019 30 Supplement 4:iv123-iv123
Databáze: ScienceDirect